Coherus Oncology, Inc. · NASDAQ:CHRS

Thomas A. Satterfield, Jr.'s stake in Coherus Oncology, Inc. fell to 4.60% (Schedule 13G/A)

Event Mar 31, 2026 · Filed Apr 29, 2026

Thomas A. Satterfield, Jr.'s stake in Coherus Oncology, Inc. fell to 4.60%, 6,930,000 shares, as a passive investor on Mar 31, 2026. Filed Apr 29, 2026 (Schedule 13G/A).

Stake
4.60%
Shares
6,930,000
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
Thomas A. Satterfield, Jr.4.60%6,930,000

Source

View original at SEC

Related